Then mapping the expression of 10 GPCRs in the OS atlas (Figure 8D), the results showed that CCR4 was mainly expressed in tumor-infiltrating lymphocytes (TILs), and its positive-cell proportion (PCP) in the tumor micro-environment was about 0.046%. This evidence concerns the gene CCR4 and neoplasm.